FCI LacriJet®, an FCI Exclusive

LacriJet® is FCI's latest and exclusive preloaded & self-retaining monocanalicular nasolacrimal intubation indicated for epiphora, congenital nasolacrimal duct obstruction and canalicular laceration.

Lacri Jet first

LACRIJET® FOR NASOLACRIMAL DUCT OBSTRUCTION

LacriJet® is first introduced into the nasolacrimal duct. Once in position, the sliding piston is retracted and the silicone intubation is released. It is maintained in place at the punctum by a plug-like fixation head: no nasal retrieval, no knot and no sutures are needed. It consists of a single use injector handpiece into which a silicone tube is preloaded inside a metallic probe. LacriJet® has been specifically designed to reduce operating time, either in the intubation phase as well as for the removal of the device.

LACRIJET® FOR CANALICULAR LACERATION

LacriJet® 15 mm and 20 mm have been specifically designed for canalicular laceration repair to prevent future canalicular obstruction due to scar tissue formation.

The LacriJet® is used like a metal probe to facilitate the catheterization between the distal and proximal portions of the canaliculus.

Main characteristics

• Exclusive new injection system
• Available in 7 lengths
• 3 mm plug collarette
• Sterile, Single use